Interference by biological anti-cancer drugs in electrophoretic and immunofixation techniques

被引:0
|
作者
Cigliana, Giovanni [1 ]
Illuminati, Gaia [1 ]
De Santis, Elena [1 ]
Conti, Laura [1 ]
Pisani, Francesco [2 ]
La Malfa, Antonella [3 ]
Longhi, Ermanno [4 ]
Gottardi, Ornella [5 ]
D'Ambrosio, Mario [5 ]
Gelsumini, Silvia [6 ]
Vernocchi, Arialdo [4 ]
机构
[1] Natl Canc Inst Regina Elena, Clin Pathol, Via Elio Chianesi 53, I-00144 Rome, Italy
[2] Natl Canc Inst Regina Elena, Hematol & Transplantat Dept, Rome, Italy
[3] Natl Canc Inst Regina Elena, Dept Pharm, Rome, Italy
[4] MultiMed Inst, Lab Med, Milan, Italy
[5] MultiMed Inst, Dept Oncol, Milan, Italy
[6] Univ Hosp Osped Circolo & Fdn Macchi, Lab Med, Varese, Italy
关键词
biological drug; interference; M-protein; CLINICAL-PRACTICE GUIDELINES; PROTEIN ELECTROPHORESIS; DIAGNOSIS;
D O I
10.1515/cclm-2015-1081
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:E297 / E299
页数:3
相关论文
共 50 条
  • [1] Therapeutic monoclonal antibody interference in electrophoretic and immunofixation techniques
    Sahinovic, I.
    Sincic-Petricevic, J.
    Orsic-Fric, V.
    Borzan, V.
    Pavela, J.
    Fijacko, M.
    Seric, V.
    CLINICA CHIMICA ACTA, 2019, 493 : S45 - S46
  • [2] Circadian biological rhythms and chronopharmacotherapy of anti-cancer drugs
    Koyanagi, Satoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 41P - 41P
  • [3] ANALYSIS OF ANTI-CANCER DRUGS IN BIOLOGICAL-FLUIDS
    STERNSON, LA
    PHARMACY INTERNATIONAL, 1981, 2 (07): : ABS1 - ABS1
  • [4] Anti-cancer drugs
    Bergmann-Leitner, ES
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [5] Anti-cancer drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [6] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [7] Paclitaxel biological synthesis promotes the innovation of anti-cancer drugs
    Zhang, Xiaolin
    Liu, Gang
    Yan, Jianbin
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (02):
  • [8] Teratogens as anti-cancer drugs
    Blagosklonny, MV
    CELL CYCLE, 2005, 4 (11) : 1518 - 1521
  • [9] Development of Anti-cancer Drugs
    Arrondeau, Jennifer
    Gan, Hui K.
    Razak, Albiruni R. A.
    Paoletti, Xavier
    Le Tourneau, Christophe
    DISCOVERY MEDICINE, 2010, 10 (53) : 355 - 362
  • [10] TESTING ANTI-CANCER DRUGS
    不详
    LANCET, 1972, 1 (7755): : 827 - +